VeriMomchamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract hamilelikte güvenli mi?
No harmonised reproductive hazard (ECHA Annex VI) or SCCS/CIR reproductive prohibition for topical extracts of Chamomilla recutita, Lavandula angustifolia, Melissa officinalis, Rosmarinus officinalis or Salvia officinalis in cosmetic use; CIR assessments and cosmetic ingredient databases list these botanicals as acceptable 'as used' with no pregnancy-specific classification. Limited case reports (e.g., lavender oil endocrine-related case series) and some in vitro endocrine activity have been discussed in PubMed, but they do not constitute harmonised H361/H360 classifications or robust in vivo human reproductive hazard that would change the default scoring.
Related ingredients
Frequently asked questions
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract hamilelikte güvenli mi?
- No harmonised reproductive hazard (ECHA Annex VI) or SCCS/CIR reproductive prohibition for topical extracts of Chamomilla recutita, Lavandula angustifolia, Melissa officinalis, Rosmarinus officinalis or Salvia officinalis in cosmetic use; CIR assessments and cosmetic ingredient databases list these botanicals as acceptable 'as used' with no pregnancy-specific classification. Limited case reports (e.g., lavender oil endocrine-related case series) and some in vitro endocrine activity have been discussed in PubMed, but they do not constitute harmonised H361/H360 classifications or robust in vivo human reproductive hazard that would change the default scoring.
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract emzirirken güvenli mi?
- Topical cosmetic use of these plant extracts is not flagged by CIR or SCCS as contraindicated in lactation; no harmonised classification for developmental or lactation toxicity. Systemic exposure from routine topical cosmetic application is generally low and there are no authoritative recommendations to avoid these extracts during breastfeeding.
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract bebek cildi için güvenli mi?
- Hazard and mechanism default to 0 based on lack of harmonised reproductive/developmental classification and CIR/SCCS acceptance for cosmetic use. Exposure is increased for infants (immature skin barrier, higher surface-area-to-weight), so exposure score is raised to 1. Note: botanical extracts can contain allergens or act as mild sensitizers (documented for some Chamomilla and Lavandula preparations in PubMed/EWG/CosIng), so consideration of formulation concentration and patch-testing for infants is prudent.
- VeriMom chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract nasıl puanlıyor?
- VeriMom chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.